本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mangoceuticals, Inc.

0.3876
+0.00451.17%
盤前0.3760-0.0116-2.99%06:37 EDT
成交量:55.94萬
成交額:21.69萬
市值:835.95萬
市盈率:-0.33
高:0.4090
開:0.3600
低:0.3600
收:0.3831
52周最高:2.75
52周最低:0.1620
股本:2,156.74萬
流通股本:1,782.95萬
量比:0.52
換手率:3.14%
股息:- -
股息率:- -
每股收益(TTM):-1.1720
每股收益(LYR):-2.1664
淨資產收益率:-95.10%
總資產收益率:-47.95%
市淨率:0.67
市盈率(LYR):-0.18

資料載入中...

2026/08/21

重要事件披露

Form 8-K - Current report
2026/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/08/06

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/08/05

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/08/05

重要事件披露

Form 8-K - Current report
2026/07/30

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/07/30

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/03

重要事件披露

Form 8-K - Current report
2026/05/20

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/01

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/18

重要事件披露

Form 8-K - Current report
2026/02/24

重要事件披露

Form 8-K - Current report
2026/02/20

重要事件披露

Form 8-K - Current report
2026/02/06

重要事件披露

Form 8-K - Current report
2026/01/26

SEC問詢函

Form CORRESP - Correspondence
2026/01/23

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/01/13

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933